logo
ENTITY

InflaRx NV (IFRX US)

9
Analysis
Health Care • United States
InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
more
Company Event • 21 Mar 2025 21:30 • Upcoming
Add To Calendar

Q4 2024

Company Event • 08 Nov 2024 22:30 • Upcoming
Add To Calendar

Q3 2024

Company Event • 08 Aug 2024 21:30 • Upcoming
Add To Calendar

Q2 2024

Company Event • 08 May 2024 19:00 • Upcoming
Add To Calendar

Q1 2024

Company Event • 21 Mar 2024 20:00 • Latest

Investor Update

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x